Open AccessRelation Between Change in Blood Pressure in Acute Stroke and Risk of Early Adverse Events and Poor Outcome
Author(s) -
Else Charlotte Sandset,
Gordon Murray,
Philip M. Bath,
Sverre E. Kjeldsen,
Eivind Berge
Publication year - 2012
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.647362
Subject(s) - medicine , stroke (engine) , blood pressure , acute stroke , adverse effect , intensive care medicine , cardiology , mechanical engineering , tissue plasminogen activator , engineering
The Scandinavian Candesartan Acute Stroke Trial (SCAST) found no benefits of candesartan in acute stroke. In the present analysis we aim to investigate the effect of change in blood pressure during the first 2 days of stroke on the risk of early adverse events and poor outcome.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom